Caribou Biosciences, Inc. (CRBU) Social Stream
CARIBOU BIOSCIENCES INC (CRBU) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CARIBOU BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 3 | $33 | $27 | $30.666 | $7.29 | 320.66% |
| 2021-11-15 | 3 | $33 | $27 | $30.666 | $7.29 | 320.66% |
| 2021-11-30 | 5 | $33 | $27 | $30 | $7.29 | 311.52% |
| 2022-01-28 | 5 | $36 | $27 | $31.2 | $7.29 | 327.98% |
| 2022-02-14 | 6 | $36 | $19 | $29.166 | $7.29 | 300.08% |
| 2022-03-21 | 7 | $36 | $19 | $28.142 | $7.29 | 286.04% |
| 2022-05-09 | 7 | $36 | $19 | $27 | $7.29 | 270.37% |
| 2022-08-10 | 7 | $39 | $19 | $29.428 | $7.29 | 303.68% |
| 2022-08-13 | 7 | $39 | $19 | $29 | $7.29 | 297.81% |
| 2022-08-18 | 7 | $39 | $19 | $28.857 | $7.29 | 295.84% |
| 2022-11-08 | 7 | $38 | $19 | $28.714 | $7.29 | 293.88% |
| 2022-12-12 | 7 | $38 | $19 | $28.571 | $7.29 | 291.92% |
| 2023-01-26 | 7 | $38 | $19 | $29.285 | $7.29 | 301.71% |
The Trend in the Analyst Price Target
CRBU's average price target has moved down $0.14 over the prior 36 weeks.
CRBU reports an average of 223.9% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-21 | 7 | 36 | 19 | 27.714 | 9.15 | 202.89% |
| 2022-03-21 | 7 | 36 | 19 | 28.142 | 9.15 | 207.56% |
| 2022-05-09 | 7 | 36 | 19 | 27.142 | 6.67 | 306.93% |
| 2022-08-18 | 7 | 39 | 19 | 28.857 | 10.33 | 179.35% |
| 2023-01-26 | 7 | 38 | 19 | 29.285 | 6.94 | 321.97% |
CRBU Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.14 | 6 | 1 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 92 days, CRBU's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRBU as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, CARIBOU BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 1529.7% of them.
- CRBU has a lower variance in analysts' estimates than -868.76% of all US stocks.
- CRBU has a higher number of analysts covering the stock than 1273.88% of stocks in the small market cap category.
- CRBU has a greater average analyst price target than 1205.36% of stocks in the small market cap category.
Stocks similar to CARIBOU BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FUSN, PSTX, and ITOS.
View All Top Stocks by Price Target
Make investment decisions regarding CRBU using the data that counts. Try POWR Ratings for free.